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Abstract
Background: The use of pain-relieving drugs during labor is now part of standard care in many countries throughout the world.
Each method of pain relief has its own risks and benefits, variations in effectiveness, and availability and acceptability.
Objectives: This study aimed to assess the efficacy and safety of intramuscular pethidine as an analgesic during labor by comparing
it to inhaled 50% nitrous oxide (Entonox).
Methods: In this clinical trial study, 100 women who expected to have a natural childbirth were observed. The inclusion criteria for
this study were the commencement of spontaneous labor pain along with appropriate maternal and fetal indications for vaginal
delivery. By using random numbers, each subject was randomly allocated to one of two groups, with one group using Entonox and
the other receiving an intramuscular injection of 0.5 mg/kg of pethidine for pain relief. The intensity of labor pain experienced by
the subjects and the outcomes of the deliveries were collected with questionnaires.
Results: The average pain scores in the Entonox and pethidine groups were 3.94± 1.4 and 5.6± 1.1, respectively, 30 minutes after
intervention (P = 0.001), but there was not a significant difference in the severity of the pain (5.06± 1.4 and 4.7± 1.1 for the Entonox
and pethidine groups, respectively) between the subjects in each group 60 minutes after the intervention (P = 0.592). No significant
differences were seen in the duration and interval of uterine contractions, maternal complications, Apgar scores, and the duration
of the first and second stage of labor between the two studied groups (P > 0.05). An analysis of the pooled risk differences showed
that none of the side effects investigated were significantly different between the two groups except for mouth dryness, which was
significantly higher in nitrous oxide users (P = 0.044).
Conclusions: Inhaled nitrous oxide seems to give better pain relief in the short term compared to a single dose of pethidine.
Entonox, which is more convenient to administer than an intramuscular injection of pethidine, is also regarded as safe both for
mothers and neonates.
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1. Background
Pain is a major public health issue throughout the
world and represents a major clinical, social, and eco-
nomic problem (1, 2). Labor pain is one of the most acute
pains that women experience during their lives (3). The
psychological effects of severe pain should not be ignored,
especially when they are associated with adverse maternal
or fetal outcomes.
There are different methods of pain relief used during
labor with different side effects and efficacies. One of the
most common methods is the inhalation of 50% nitrous
oxide (4, 5). Nitrous oxide is an odorless, tasteless, inhaled
analgesic (6) that has been found to be an effective anal-
gesic for many women that is safe for both mothers and
babies (4). Use of nitrous oxide during labor began in the
late 1800s, and Minnitt in England introduced equipment
for self-administration in 1934. Nitrous oxide is usually run
through a mouth mask intermittently, starting about 30
seconds before each contraction (7, 8). Inhalation of 50%
nitrous oxide can significantly decrease anxiety without
clinically significant side effects, and its effects are quickly
reversible upon discontinuation of inhalation (8, 9).
Pethidine or meperidine hydrochloride was the first
synthetic opioid, synthesized in 1932 (9). Systemic pethi-
dine is routinely used throughout the UK for labor analge-
sia (10, 11). However, systemic opioids lead to some compli-
cations for mothers (12, 13) and babies (14). Since pethidine
passes through the placenta, pethidine may accumulate in
the fetal circulation (8), causing early neonatal respiratory
depression and behavioral and feeding problems for up to
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six weeks after delivery (14).
2. Objectives
In present study, we aimed to assess the safety of us-
ing inhaled 50% nitrous oxide as an analgesic during labor
in comparison to intramuscular pethidine among women
undergoing normal vaginal delivery.
3. Methods
This study was a randomized clinical trial conducted
in Alavi hospital (Ardabil, Iran) in 2015. One hundred preg-
nant women who were in the initial phase of labor were en-
rolled in study. The sample size was calculated with a con-
fidence of 95% and a power of 80%.
3.1. Patient Selection
The inclusion criteria for this study were the com-
mencement of spontaneous labor pain along with appro-
priate maternal and fetal indications for vaginal delivery.
The exclusion criteria were the presence of a personality
disorder, an addiction, a complicated pregnancy, diabetes
mellitus, macrosomia, chronic obstructive pulmonary dis-
ease, an unconfident fetal heart rate, valvular heart disease,
an upper respiratory tract infection or sinus obstruction, a
history of asthma, and contraindications for Entonox and
pethidine usage.
By using random numbers, the subjects were ran-
domly allocated into two groups, with one group using
Entonox and the other receiving an intramuscular injec-
tion of 0.5 mg/kg of pethidine for pain relief.
3.2. Ethics Declaration
The study was reviewed and approved by the Ardabil
University of Medical Science Ethics Committee. Infor-
mation about the study was given comprehensively to
all patients. Informed consent was obtained from all pa-
tients according to the University Ethical Committee. This
study has been registered at www.irct.ir with the code IRCT
201503244256N6.
3.3. Data Collection
A questionnaire to collect information about the pa-
tients’ demographic characteristics, their severity of pain,
the duration of the first and second stage of labor, the dura-
tion and interval of uterine contractions, any neonatal and
maternal complications, and the side effects of drugs was
completed by the researcher through the intervention.
Patients were taught to use an Entonox face mask at the
beginning of uterine contractions and to continue deep in-
spirations at times when there was pain and cramps. Use of
Entonox could be started or cut at any moment during la-
bor according to the needs and preferences of the woman.
The pethidine group received an intramuscular injec-
tion of 0.5 mg/kg of pethidine. If a patient’s pain rated
higher than 5 VAS, 0.25 mg/kg of pethidine was injected.
Each patient’s parturient pain scored was evaluated ac-
cording to their VAS score, which was graded from 0 to 10
(0 = no pain and 10 = severe and intolerable pain) once be-
fore any analgesic administrations and twice at 30 and 60
minutes after analgesic administration using a structured
questionnaire and a subjective labor pain scale (visual-
analogue scale).
The vital signs of all parturient were monitored. The
main outcomes (pain score, duration of the first and sec-
ond phase of the labor, and Apgar scores at one and five
minutes) were recorded prospectively by one person with
one technique. For comparison studies between the two
groups, a cervical dilatation of four to five cm was consid-
ered the signal of the start of the active phase of labor.
3.4. Statistical Analysis
The results were reported as mean ± standard devia-
tion (SD) for the quantitative variables and percentages for
the categorical variables. The groups were compared us-
ing a t-test for the continuous variables and a chi-squared
test for the categorical variables. A P value ≤ 0.05 was
considered to be statistically significant. All the statistical
analyses were performed using SPSS version 15.0 (SPSS Inc.,
Chicago, IL, USA) for windows.
4. Results
Of the 107 pregnant women were enrolled in this study,
seven were excluded by the exclusion criteria.
The majority of women in this study were in the 21 - 30-
year age range. The mean maternal age was 26.2 and 27.2
in the Entonox and pethidine groups, respectively. The de-
mographic data of the participants is summarized in Table
1.
The average pain scores 30 minutes after intervention
in the Entonox and pethidine groups were 3.94 ± 1.4 and
5.6 ± 1.1, respectively, (P = 0.001), but there was not a sig-
nificant difference in the severity of the pain between the
two groups 60 minutes after intervention (P > 0.05). No
significant differences were seen in the duration and in-
terval of uterine contractions, maternal complications, Ap-
gar score, and in the duration of the first and second stage
of labor between the two studied groups (P > 0.05). An
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Table 1. The Frequency Distribution of the Demographic Characteristics of the Pregnant Women in the Intervention Groupsa
Characteristics Entonox (n = 50) Pethidine (n = 50) Total Number P Value
Age, y
< 20 16 (32) 9 (18) 4 (4)
21 - 30 29 (58) 34 (68) 63 (63)
31 - 40 5 (10) 7 (14) 12 (12)
Habitant 0.099
Village 13 (26) 16 (32) 29 (29)
City 37 (74) 34 (68) 71 (71)
Level of Education 0.002
Illiterate 1 (2) 1 (2) 2 (2)
Junior and Senior High School 27 (54) 29 (58) 56 (56)
Diploma and University 22 (44) 20 (40) 42 (42)
Gestation (weeks),mean± SD 38.86± 2.95 38.36± 2.11 NS
aValues are expressed as No. (%) unless otherwise indicated.
analysis of the pooled risk differences showed that none of
the side effects investigated were significantly different be-
tween the two groups except for mouth dryness, which was
significantly higher in the nitrous oxide users (P = 0.044)
(Table 2).
5. Discussion
Nitrous oxide has low solubility in blood and is trans-
ported in a solution without binding to protein. Nitrous
oxide takes effect rapidly (15) because it spreads rapidly
through the lining of the arterial alveolar membrane and
is excreted unchanged mainly through the lungs (6). As
a result, the effects of nitrous oxide are quickly reversible
upon the discontinuation of therapy (16). The recovery
time from the effects of nitrous oxide sedation is faster
than that of intravenous analgesia (6).
The analgesic effect of pethidine starts within 10 - 20
minutes and lasts two to four hours after being adminis-
tered intramuscularly (17). The rate of use of parental opi-
oids was between 39% and 56% in various hospital obstet-
rics units in the United States (10). However, many studies
have suggested that intramuscular pethidine may be inef-
fective at relieving labor pain and that their use may even
be unethical and medically incorrect (18, 19).
In this study, pain severity, which was defined accord-
ing to a patient’s VAS score, was significantly lower in pa-
tients who received nitrous oxide 30 minutes after inter-
vention, but there was not a significant difference in the
severity of pain between the patients in the two groups 60
minutes after intervention.
Research has shown that 80% or more of a 100-mg dose
of pethidine administered intramuscularly is absorbed
over six hours with a mean time of maximum plasma con-
centration of approximately 24 minutes. With intramus-
cularly administered pethidine, analgesia may persist for
two to four hours following intramuscular, intravenous, or
subcutaneous administration (12).
With an intramuscular pethidine injection, appropri-
ate levels of pethidine still exist in the plasma 60 minutes
after intervention. In contrast, Entonox consumption re-
quires more cooperation from patients. With the progres-
sion of labor and the exacerbation of pain, participants’
cooperation with Entonox use decreases, which might in-
crease a patient’s 60-minute pain score compared to their
30-minute score.
No significant changes in the maternal cardiorespira-
tory parameters were noted with either of the two anal-
gesics. Associated factors and transplacental transmission
of the analgesic from mother to fetus can affect the Apgar
scores of the babies at birth. The ideal analgesic is one that
has no adverse effect on the fetus. In our study, the Apgar
scores of the babies at birth were satisfactory, and no sig-
nificant difference was observed between infant complica-
tions and Apgar scores in the two groups.
Abdollahi et al. concluded that intravenous paraceta-
mol was more effective than intramuscular pethidine at re-
lieving labor pain in normal vaginal deliveries (19).
Pasha et al. showed that the use of 50% nitrous oxide
caused less labor pain, favorable expectations and expe-
riences, and also greater maternal satisfaction compared
with a control group that did not receive gas (20).
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Table 2. Descriptive Data of the Entonox and Pethidine Subjects
Characteristics Entonox Pethidine P Value
Duration
First stage, hour 3.15± 1.65 3.65± 1.76 0.124
Second stage, minute 33.7± 13.2 31.6± 7.5 0.124
VASmean score
Before analgesia 7.38± 2 7.3± 1.1 0.812
30 minutes after analgesia 3.94± 1.4 5.6± 1.1 0.044
60 minutes after analgesia 5.06± 1.4 4.7± 1.1 0.592
Systolic blood pressure
Before analgesia 113.33± 12.64 114.32± 8.52 0.185
After analgesia 115.67± 9.12 114.39± 8.21 0.067
Duration of uterine contractions
Before analgesia 39.32± 9.12 38.82± 7.21 0.12
After analgesia 40.32± 6.12 41.32± 5.45 0.08
Interval of uterine contractions
Before analgesia 120.72± 32.61 129.35± 8.66 0.34
After analgesia 123.37± 46.47 118.39± 3.67 0.09
Apgar score
First minute 9± 0.1 8± 9 0.465
Fifth minute 9.91± 0.4 9.88± 0.2 0.598
An analysis of the pooled risk differences showed that
none of the side effects investigated were significantly
different between the two groups except mouth dryness,
which was significantly higher in nitrous oxide users.
As a result, inhaled nitrous oxide seems to give better
pain relief in the short term compared to a single dose
of pethidine. Since Entonox is more convenient to ad-
minister, it is also regarded as safe for both mothers and
neonates.
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